EUVIMEDEUVIMED entdecken
Crossref

Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling

Bernhard Lesch iD, Alexander Birkmann iD, Susanne Bonsmann, Alastair Donald, Florian Engel, Thomas Goldner, Kamal Kumar, Tamara Pfaff, Andreas Urban, Holger Zimmermann, Alexandra E Bosnidou, Estefanía Del Castillo und 11 weitere

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c02838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Bernhard Lesch und 22 weiteren Autor:innen. Beteiligte Einrichtung: AiCuris Anti-infective Cures AG, Friedrich-Ebert-Str.475/Geb.302, 42117 Wuppertal, Germany. Hauptthemen laut MEDLINE: Hepatitis B virus, Antiviral Agents, Virus Assembly. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B Virus (HBV) infections remain a threat to the global public health. Nucleoside analogues remain the mainstay of therapy despite their discouraging cure rates achieved. Capsid assembly modulators (CAMs) have been at the center of HBV research, but despite having shown clinical efficacy on viral load in clinical studies, market entry has been elusive. Herein, we present the optimization program of our lead series. Setting our focus on potency, solubility, and hERG liability, these studies resulted in AIC263282, a new, potent capsid assembly modulator with improved physicochemical properties, which is ready for profiling as a preclinical candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusAntiviral AgentsVirus AssemblyHumansAnimalsCapsidStructure-Activity RelationshipDrug DiscoveryCapsid ProteinsRats

Substanzen

Antiviral AgentsCapsid Proteins

Autor:innen und Institutionen

  • AiCuris Anti-infective Cures AG, Friedrich-Ebert-Str.475/Geb.302, 42117 Wuppertal, Germany.
  • Institute of Chemical Research of Catalonia (ICIQ), Barcelona Institute of Science and Technology (BIST), Avgda. Països Catalans 16, 43007 Tarragona, Spain.
  • Symeres, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands.

ORCID-Profile: Bernhard Lesch, Alexander Birkmann

Förderung

  • HORIZON EUROPE Marie Sklodowska-Curie Actions

Zitieren

APA

Lesch, B., Birkmann, A., Bonsmann, S., Donald, A., Engel, F., Goldner, T., Kumar, K., Pfaff, T., Urban, A., Zimmermann, H., Bosnidou, A. E., Del Castillo, E., Cuevas, F., Detta, E., Font, D., García, J. G., Raymond, J., Sarmentero, M. Á., Cnossen, A., …, & Buschmann, H. (2025). Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02838

Vancouver

Lesch B, Birkmann A, Bonsmann S, Donald A, Engel F, Goldner T, et al. Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02838

BibTeX
@article{Lesch2025,
  author = {Lesch, Bernhard and Birkmann, Alexander and Bonsmann, Susanne and Donald, Alastair and Engel, Florian and Goldner, Thomas and Kumar, Kamal and Pfaff, Tamara and Urban, Andreas and Zimmermann, Holger and Bosnidou, Alexandra E and Del Castillo, Estefanía and Cuevas, Félix and Detta, Elena and Font, Daniel and García, Jordi González and Raymond, Justine and Sarmentero, Maria Ángeles and Cnossen, Arjen and Sinnige, Wessel and Slootweg, Jack C and Wegert, Anita and Buschmann, Helmut},
  title = {Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c02838}
}
Kostenlos starten →